Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

被引：0
|
作者：
Kovtun, K. [1 ,2 ]
Moser, J. A. [1 ]
Callery, M. [1 ]
Kent, T. [1 ]
Tseng, J. [1 ]
Miksad, R. [1 ]
Bullock, A. [1 ]
Schlechter, B. [1 ]
Mahadevan, A. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Radiat Oncol Program, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2486
引用
收藏
页码：E198 / E198
页数：1
相关论文
共 50 条
  • [31] The surgical outcomes of borderline resectable or locally advanced pancreatic cancer
    Okamura, Yukiyasu
    Sugiura, Teiichi
    Ito, Takaaki
    Yamamoto, Yusuke
    Ashida, Ryo
    Ohgi, Katsuhisa
    Uesaka, Katsuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [32] Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?
    Daniel M. Halperin
    Gauri R. Varadhachary
    Current Oncology Reports, 2014, 16
  • [33] Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?
    Halperin, Daniel M.
    Varadhachary, Gauri R.
    CURRENT ONCOLOGY REPORTS, 2014, 16 (02)
  • [34] Cutting Through Confusion: Multimodality Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
    Kasumova, Gyulnara G.
    Miksad, Rebecca A.
    Tseng, Jennifer F.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (10) : 924 - +
  • [35] Updates on the Use of Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Chandhok, Namrata Sonia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2014, 15 (02): : 91 - 94
  • [36] Outcome Following Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
    Stokes, J. B.
    Walters, D. M.
    Norris, N. J.
    Stelow, E. B.
    Rich, T. A.
    Weiss, G. R.
    De Lange, E. E.
    Adams, R. B.
    Bauer, T. W.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 80 - 80
  • [37] Adjuvant Therapy versus neoadjuvant Therapy for Borderline resectable Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (05): : 457 - 457
  • [38] Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
    O'Reilly, Eileen M.
    Ferrone, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1757 - +
  • [39] Neoadjuvant FOLFIRINOX for patients with borderline resectable or locally advanced pancreatic cancer: Results of a decision analysis.
    Choi, Jin
    Nipp, Ryan David
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Kong, Chung Yin
    Pandharipande, Pari
    Dowling, Emily
    Ferrone, Cristina
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-del Castillo, Carlos
    Ryan, David P.
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer
    Zhang, Chunmeng
    Wu, Ruiqian
    Smith, Lynette M.
    Baine, Michael
    Lin, Chi
    Reames, Bradley N.
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (01): : 51 - 57
12345